Conservative treatment of an early aortic graft infection due to Acinetobacter baumanii

Ann Vasc Surg. 2006 May;20(3):415-7. doi: 10.1007/s10016-006-9030-2. Epub 2006 Apr 7.

Abstract

Acute infection of an aortic graft is a devastating complication. While resection of the infected prosthesis and extra-anatomic bypass is the established treatment, this carries a high mortality. We describe a case of early aortic graft infection with the unusual organism Acinetobacter baumanii, which was eradicated by a combination of surgical drainage and antibiotics, allowing preservation of the graft. The patient remains well 30 months later.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter baumannii / isolation & purification
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Aortic Aneurysm, Abdominal / surgery
  • Blood Vessel Prosthesis / adverse effects*
  • Blood Vessel Prosthesis Implantation
  • Combined Modality Therapy
  • Debridement*
  • Female
  • Gentamicins / therapeutic use
  • Humans
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / therapeutic use
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / surgery*
  • Rifampin / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Rifampin
  • Piperacillin